Literature DB >> 15658934

Osmotic pumps in drug delivery.

Rajan K Verma1, Sachin Arora, Sanjay Garg.   

Abstract

In recent years, novel drug delivery systems (NDDS) have been recognized as an attractive niche for the pharmaceutical and health industry. Among various NDDS, osmotic pumps have matured from their use with laboratory animals to the most reliable controlled release systems for humans. Osmotically controlled drug delivery systems use osmotic pressure for controlled delivery of active agent(s). Drug delivery from these systems, to a large extent, is independent of the physiological factors of the gastrointestinal tract. Because of their unique advantages over other types of dosage forms, osmotic pumps form a class of their own among the various drug delivery technologies, and a variety of products based on this technology are available on the market. This article is a review of different types of osmotic pumps and their role in drug delivery.

Entities:  

Mesh:

Year:  2004        PMID: 15658934     DOI: 10.1615/critrevtherdrugcarriersyst.v21.i6.20

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  6 in total

Review 1.  Enabling individualized therapy through nanotechnology.

Authors:  Jason H Sakamoto; Anne L van de Ven; Biana Godin; Elvin Blanco; Rita E Serda; Alessandro Grattoni; Arturas Ziemys; Ali Bouamrani; Tony Hu; Shivakumar I Ranganathan; Enrica De Rosa; Jonathan O Martinez; Christine A Smid; Rachel M Buchanan; Sei-Young Lee; Srimeenakshi Srinivasan; Matthew Landry; Anne Meyn; Ennio Tasciotti; Xuewu Liu; Paolo Decuzzi; Mauro Ferrari
Journal:  Pharmacol Res       Date:  2010-01-05       Impact factor: 7.658

2.  Zero-order controlled release of ciprofloxacin-HCl from a reservoir-based, bioresorbable and elastomeric device.

Authors:  Irene S Tobias; Heejin Lee; George C Engelmayr; Daniel Macaya; Christopher J Bettinger; Michael J Cima
Journal:  J Control Release       Date:  2010-06-04       Impact factor: 9.776

Review 3.  Scientific and Regulatory Considerations in Solid Oral Modified Release Drug Product Development.

Authors:  Min Li; Sanna Sander; John Duan; Susan Rosencrance; Sarah Pope Miksinski; Lawrence Yu; Paul Seo; Bhagwant Rege
Journal:  AAPS J       Date:  2016-09-20       Impact factor: 4.009

Review 4.  Therapeutic strategies based on polymeric microparticles.

Authors:  C Vilos; L A Velasquez
Journal:  J Biomed Biotechnol       Date:  2012-05-16

5.  Development, evaluation, and influence of formulation and process variables on in vitro performance of oral elementary osmotic device of atenolol.

Authors:  N Arjun; D Narendar; K Sunitha; K Harika; B Nagaraj
Journal:  Int J Pharm Investig       Date:  2016 Oct-Dec

Review 6.  What's Hot in HIV in 2019-A Basic and Translational Science Summary for Clinicians From IDWeek 2019.

Authors:  Boghuma Titanji; Colleen F Kelley
Journal:  Open Forum Infect Dis       Date:  2020-02-13       Impact factor: 3.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.